Retrograde signaling pathways and changes in cardiac metabolism induced bymitochondrial dysfunction in Barth syndrome
Retrograde signaling pathways and changes in cardiac metabolism induced bymitochondrial dysfunction in Barth syndrome
批准号:
423600288
负责人:
Dr. Jan Alexander Dudek
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Barth syndrome (BTHS) is an inherited form of cardiomyopathy, caused by a defect in the biogenesis of the mitochondrial phospholipid cardiolipin (CL). CL deficient cardiac mitochondria show a structural remodeling of the respiratory chain, a decreased respiration and an increased generation of reactive oxygen species (ROS). In this project, we will address the hypothesis that mitochondrial dysfunction is sensed by a retrograde signaling pathway and triggers an adaptive remodeling of cellular metabolism. Using the BTHS mouse model and patient derived iPSC cardiomyocytes (iPSC-CM) we will test the hypothesis that the induction of the integrated stress response pathway (ISR) and the stabilization of the stress induced transcription factor ATF5 is involved in changes in gene transcription. We are highly interested in the molecular mechanism, how retrograde signaling is activated by dysfunctional mitochondria. We will dissect the upstream signaling pathways by identifying the sensor kinases, responsible for the activation of the ISR pathway. By interference with genes involved in different stages of CL biosynthesis, we will create different CL pools and monitor ISR activation. In order to analyze the involvement of ROS in ISR activation, we will quench ROS in the BTHS mouse model by the expression of the plant alternative oxidase (AOX). We are interested in the molecular mechanism of the stabilization of the retrograde response transcription factor ATF5. ATF5 is imported into mitochondria and subsequently degraded in cells with unaffected mitochondria. Using an in vitro import assay, we will test the hypothesis that mitochondrial dysfunction induces a block of mitochondrial transport allowing ATF5 to stabilize and induce gene transcription in the nucleus.We will address the role of these pathways in metabolic remodeling in the heart. Fatty acids play a predominant role in supporting the energy demand in cardiac tissue. Our preliminary data show a significant reduction in -oxidation in BTHS mouse model and patient derived iPSC-CM. We will test the hypothesis that ISR signaling induces a remodeling of mitochondrial metabolism, thereby reducing fatty acid oxidation, which is particularly prone to ROS-generation. We also test the role of the mitochondrial LONP1 protease in inducing structural changes in the respiratory chain and exchanging regulatory subunits of the cytochrome c oxidase and other complexes of the respiratory chain. Respiratory chain remodeling and increased ROS production are common to many mitochondriopathies. Here we will shed light into a general mechanism how mitochondrial dysfunction is monitored by retrograde signaling and triggers an adaptive nuclear response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
-
批准号:82370684
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅强
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
-
批准号:32370928
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:孙钦秒
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: